Free Trial
NYSE:USPH

U.S. Physical Therapy (USPH) Stock Price, News & Analysis

$77.48
-1.01 (-1.29%)
(As of 10/8/2024 ET)

About U.S. Physical Therapy Stock (NYSE:USPH)

Key Stats

Today's Range
$77.44
$80.11
50-Day Range
$77.48
$97.50
52-Week Range
$76.18
$113.63
Volume
162,612 shs
Average Volume
88,225 shs
Market Capitalization
$1.17 billion
P/E Ratio
62.99
Dividend Yield
2.27%
Price Target
$105.00
Consensus Rating
Moderate Buy

Company Overview

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

U.S. Physical Therapy Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
86th Percentile Overall Score

USPH MarketRank™: 

U.S. Physical Therapy scored higher than 86% of companies evaluated by MarketBeat, and ranked 121st out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    U.S. Physical Therapy has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    U.S. Physical Therapy has only been the subject of 2 research reports in the past 90 days.

  • Read more about U.S. Physical Therapy's stock forecast and price target.
  • Earnings Growth

    Earnings for U.S. Physical Therapy are expected to grow by 18.33% in the coming year, from $2.51 to $2.97 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of U.S. Physical Therapy is 62.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.10.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of U.S. Physical Therapy is 62.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 125.90.

  • Price to Earnings Growth Ratio

    U.S. Physical Therapy has a PEG Ratio of 3.97. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    U.S. Physical Therapy has a P/B Ratio of 2.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about U.S. Physical Therapy's valuation and earnings.
  • Percentage of Shares Shorted

    3.19% of the outstanding shares of U.S. Physical Therapy have been sold short.
  • Short Interest Ratio / Days to Cover

    U.S. Physical Therapy has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in U.S. Physical Therapy has recently decreased by 14.84%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    U.S. Physical Therapy pays a meaningful dividend of 2.17%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    U.S. Physical Therapy does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of U.S. Physical Therapy is 143.09%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 59.26% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.

  • Read more about U.S. Physical Therapy's dividend.
  • Percentage of Shares Shorted

    3.19% of the outstanding shares of U.S. Physical Therapy have been sold short.
  • Short Interest Ratio / Days to Cover

    U.S. Physical Therapy has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in U.S. Physical Therapy has recently decreased by 14.84%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    U.S. Physical Therapy has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for U.S. Physical Therapy this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for USPH on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, U.S. Physical Therapy insiders have bought 21.06% more of their company's stock than they have sold. Specifically, they have bought $172,180.00 in company stock and sold $142,230.00 in company stock.

  • Percentage Held by Insiders

    Only 1.70% of the stock of U.S. Physical Therapy is held by insiders.

  • Read more about U.S. Physical Therapy's insider trading history.
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

[SHOCKING] Crypto Document Leak…
The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.
See More Headlines

USPH Stock Analysis - Frequently Asked Questions

U.S. Physical Therapy's stock was trading at $93.14 at the start of the year. Since then, USPH shares have decreased by 16.8% and is now trading at $77.48.
View the best growth stocks for 2024 here
.

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its earnings results on Tuesday, August, 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by $0.09. The firm's quarterly revenue was up 10.4% on a year-over-year basis.

U.S. Physical Therapy's top institutional shareholders include Azzad Asset Management Inc. ADV (0.09%), True North Advisors LLC (0.05%), Handelsbanken Fonder AB (0.02%) and Park Avenue Securities LLC (0.02%). Insiders that own company stock include Christopher J Reading, Carey P Hendrickson, Kathleen A Gilmartin, Eric Joseph Williams, Richard Binstein, Mark J Brookner, Harry S Chapman, Graham D Reeve, Clayton Trier, Edward L Kuntz and Anne Motsenbocker.
View institutional ownership trends
.

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM) and Illumina (ILMN).

Company Calendar

Last Earnings
8/13/2024
Ex-Dividend for 9/13 Dividend
8/23/2024
Dividend Payable
9/13/2024
Today
10/08/2024
Next Earnings (Estimated)
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
Health Care Facilities
CUSIP
90337L10
Employees
6,720
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$105.00
High Stock Price Target
$117.00
Low Stock Price Target
$90.00
Potential Upside/Downside
+35.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$28.24 million
Pretax Margin
7.24%

Debt

Sales & Book Value

Annual Sales
$627.67 million
Cash Flow
$4.46 per share
Book Value
$31.85 per share

Miscellaneous

Free Float
14,812,000
Market Cap
$1.17 billion
Optionable
Optionable
Beta
1.39
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (NYSE:USPH) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners